East Roseville, Australia

Alan M Johnson

This inventor holds 1 USPTO granted patent. Top assignee: The Trustees of Flinders University. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan M Johnson. Retrieved from https://idiyas.com/inventor/alan-m-johnson-cv26imxf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan M Johnson: Innovator in Toxoplasma Research

Introduction

Alan M Johnson is a notable inventor based in East Roseville, Australia. He has made significant contributions to the field of biotechnology, particularly in the study of Toxoplasma antigens. His work has implications for understanding and potentially treating infections caused by this parasite.

Latest Patents

Alan M Johnson holds a patent for the "Cloning and expression of toxoplasma antigens and use of recombinant." This patent represents a crucial advancement in the field, as it explores the potential for recombinant technology to aid in the study and treatment of Toxoplasma infections. He has 1 patent to his name, showcasing his innovative approach to scientific research.

Career Highlights

Alan is affiliated with The Flinders University of South Australia, where he conducts research and collaborates with other scientists. His work at the university has allowed him to contribute to various projects aimed at advancing knowledge in the field of parasitology.

Collaborations

One of his notable collaborators is Peter J McDonald. Together, they have worked on projects that enhance the understanding of Toxoplasma and its effects on human health.

Conclusion

Alan M Johnson's contributions to the field of biotechnology, particularly through his patent on Toxoplasma antigens, highlight his role as an innovator in scientific research. His work continues to pave the way for advancements in understanding and treating parasitic infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…